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Abstract
Purpose To analyze the follow-up results of patients suffering from symptomatic early-stage endometriosis after a consistent 
laparoscopic peritoneal stripping of the altered peritoneum (peritoneal endometriosis and surrounding inflamed tissue) was 
performed. This type of endometriosis is resistant to medical therapy and/or impairs fertility.
Methods Using our prospectively maintained database, we were able to identify all symptomatic women with the suspi-
cion of only peritoneal endometriosis who underwent laparoscopy at our endometriosis center over a period of 5 years. All 
procedures were carried out in a standardized fashion by one single surgeon, who is highly experienced in minimal invasive 
surgery, and included a suspended hormonal pretreatment for 2 months. Postoperative outcomes including complications, 
fertility and recurrence rates were analysed.
Results Laparoscopic peritonectomy was performed on 94 women. Follow-up data were available in 87% of these cases. 
At the time of surgery, almost all patients tested showed signs of stage I or II endometriosis (44.7 and 48.9%, respectively). 
More than three-quarters of the women reported pain relief, inter alia, due to the post-surgical hormonal therapy. About 
one-third of the patients wanted to have children after the procedure. 62% of them became pregnant and the majority did so 
without the need for assisted reproductive therapy. In seven women a re-operation was performed.
Conclusion According to our data, a consistent excision of altered peritoneum followed by adjuvant hormonal therapy and 
multimodal concepts results in better outcomes for the patient, particularly in regards to pregnancy and recurrence rates.
Keywords Peritoneal endometriosis · Peritonectomy · Laparoscopic surgery · Pelvic pain · Infertility
Introduction
Endometriosis is a benign chronic inflammatory disease 
affecting millions of women worldwide during their repro-
ductive years [1, 2]. The pathogenesis is still under debate, 
however, most likely, stem cell such as cells from retrograde 
menstruation adhere to the peritoneal surface and develop 
into peritoneal endometriotic lesions [3, 4]. Apart from the 
establishment of such ectopic lesions, numerous and brisk 
immune cell infiltrates were found within the microenvi-
ronment of these lesions, indicating acute immunological 
reactions [5, 6]. Both pathways are linked to each other. 
Macrophages are in the peritoneal fluid as well as in the peri-
toneal lesions and in the unaffected peritoneum from women 
with endometriosis, secreting a variety of pro-inflammatory 
cytokines and chemokines in the peritoneal fluid [7, 8]. 
Neurotrophins and neuronal guidance molecules and their 
receptors are most highly expressed in the glands of endo-
metriotic peritoneal lesions [9]. The release of nerve growth 
factors leads to changes in the peritoneal innervation [8]. 
This includes the hyperinnervation of sensory nerve fibers 
and the hypoinnervation of sympathetic nerve fibers with an 
imbalance of pro- and anti-inflammatory neurotransmitters 
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[10, 11]. As more nerve fibres were found in the areas where 
increased numbers of macrophages were identified, the den-
sity of macrophages seems to correlate with the number of 
nerve fibres, which in turn correlates with the development 
of endometriosis-related symptoms [8, 12]. Endometriosis-
associated immune cell infiltrates might be a trigger for a 
neurogenic inflammatory reaction and a critical point where 
cyclical pain becomes acyclical pelvic pain [10, 11, 13–15].
Pain is the main symptom of endometriosis patients with 
a very heterogenous variation of several symptoms including 
dysmenorrhoea, cyclical and acyclical pelvic pain, dysuria, 
dyschezia, dyspareunia etc. [16]. These symptoms have a 
negative impact on the physical, mental, and social wellbe-
ing of patients [17]. The severity of pain is independent of 
the stage/extent of the disease and the appearance and loca-
tion of endometriosis deposits [18–22]. However, pain gen-
eration is very complex and the impact of peritoneal lesions 
on pain generation is difficult to understand and differentiate 
from symptoms caused by other kinds of illness, like adeno-
myosis, deep infiltrating lesions, endometrioma or adhesions 
[23]. Many patients suffer from a combined manifestation of 
lesions and present a combination of symptoms [23].
The first step in the treatment of patients with suspected 
endometriosis symptoms should be hormonal treatment. If 
this fails then surgery should be indicated as the next treat-
ment option [24–28]. The therapeutic approach of perito-
neal endometriosis worldwide is very heterogenous. Many 
patients receive laparoscopy for the diagnostic purpose only. 
So residual foci are left behind, which should be avoided as 
an outcome depending on the completeness of the surgical 
treatment. Compared to diagnostic laparoscopy only, the sur-
gical management of mild endometriosis seems to be more 
effective in treating the symptoms of pain and improving 
the quality of life for women with endometriosis as well as 
improving their pregnancy rate [29–33].
In a randomized, placebo-controlled trial by Abbott 
et al. comparing immediate excision with delayed surgery 
on 39 women, of whom about 50% had rAFS stage I and II, 
surgery was associated with a 30% placebo response rate, 
not dependent on the severity of the disease. Approximately 
20% of women did not report an improvement after surgery 
for endometriosis [34]. In another classical study by Sutton 
et al. on the same question (but on women with mostly stage 
I disease receiving laparoscopic ablation) the nonresponse 
rate was 38% [35]. Recently a review showed that many 
women only gain limited or intermittent benefits from long-
term treatment [36].
As a consequence, early stage surgical intervention in 
endometriosis should be limited to patients with painful 
symptoms and contraindications or ones who show a poor 
response to medical therapies or in cases of subfertility [32]. 
Hormonal treatment as therapeutic attempt should always be 
performed before surgery, in particular in the absence of any 
sonographic evidence of endometriosis, to clarify the cause 
of pain and identify patients with symptomatic peritoneal 
endometriosis. The surgical approach should be reserved for 
clearly defined objectives: to reduce pain, increase patient’s 
pregnancy rate, exclude advanced stages of endometriosis or 
malignant adnexal masses and delay recurrence for as long 
as possible [37].
Aside from invasiveness, morbidity and complication 
risks, the recurrence of symptoms or lesions after surgery 
is highly concerning [38–40]. According to a review the 
2 years recurrence rate is estimated to be 21.5% [41]. The 
association between disease relapse and rARSM stages is 
still under debate, recurrence is, however, markedly pre-
vented by the administration of estroprogestins [41–45].
Sharp excision, bipolar diathermy and ablation by 
 CO2-laser are the most common techniques in laparoscopic 
surgery for endometriosis. The question of which techniques 
should be preferred to manage superficial peritoneal disease 
has not yet been answered [46] (see Table 1).
In practice, there is a tendency for gynecologic surgeons 
to prefer to perform ablation because it is considered easier. 
Theoretically, excision is advantageous because it ensures 
that the entire lesion or pathologic tissue is removed.
Table 1  OP technique






RCT Excision vs ablation with  CO2 laser 178 No significant difference at 12 months (improvement 
of patients’ symptoms in both arms). Trends in 
improvement of dyschezia and dyspareunia
Wright et al. 
(75)




Retrospective Excision vs coagulation 79 Coagulation group better for dysmenorrhea and the 
number of recurrence with subsequent surgical 
intervention (2.8 vs 18.6%)
Riley [71] RCT Excision vs ablation by using an 
argon beam coagulator
73 Ablation group better for dyspareunia at 6 months 
only. No significant difference at 12 months
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In our opinion, there is a lack of studies regarding the 
indication for surgery of peritoneal endometriotic lesions 
and the surgical procedure to treat them. This paper focuses 
on our experience and presents the follow-up results after 
laparoscopic peritoneal stripping of the altered peritoneum 
(peritoneal endometriosis and surrounding inflamed tissue).
Materials and methods
We analysed our prospectively maintained database to iden-
tify all women who underwent laparoscopy at our endome-
triosis center from January 2014 to June 2019. Women with 
a sonographic exclusion of complex endometriosis mani-
festation and symptomatic endometriosis and/or impaired 
fertility older than 18 years were included. Indication for 
surgery was only given for typical symptoms of endometrio-
sis after the failure of sufficient hormonal treatment (amen-
orrhoea > 6 months) with ongoing acyclical pelvic pain. 
The estimated endometriotic lesions were peritoneal lesions 
(with or without adenomyosis). Patients were not excluded 
if they had already been diagnosed with endometriosis. An 
initial survey of the pelvis was performed, and any patient 
found to have ovarian cysts or endometriomas, retrospec-
tively, or any signs for deep infiltrating endometriosis, was 
excluded. Exclusion criteria included further intraopera-
tive bilateral salpingo-oophorectomy and hysterectomy for 
adenomyosis. The goal was to concentrate on women with 
only peritoneal endometriosis.
The database contained all information about demo-
graphic and clinical characteristics, medical examination, 
imaging and surgical therapy. The preoperative pelvic pain 
severity was assessed by a 10-point visual analog scale 
(VAS) that was routinely performed at preoperative visits 
and covered different types of pain: dysmenorrhea, cyclic 
pain, complex chronic pain, dyspareunia, dysuria and dys-
chezia. VAS scores were a validated way to measure pain 
and used to measure overall pelvic pain as well as the dif-
ferent types of visceral pain [47]. We stated all clinically 
relevant symptoms with a score ≥ 5.
All procedures were carried out in a standardized fashion 
by one single surgeon, who is highly experienced in minimal 
invasive surgery for endometriosis. A suspended hormonal 
pretreatment for 2 months followed the surgery [48]. In all 
cases, a careful evaluation of the whole abdominal cavity 
was performed. The clinically suspected diagnosis was veri-
fied intraoperatively and all visible endometriosis implants 
and/or inflammatory altered peritoneum were radically 
excised (peritonectomy) including the removal of around 
two cm of the surrounding normal-appearing tissue (wide 
excision). For classification, we used the revised score of 
the American Society of Reproductive Medicine (rARSM) 
[49]. Excision was carried out by grasping the peritoneum 
with the endometriotic lesion, thus distancing it from the 
underlying tissue. Using laparoscopic scissors, the lesion 
along with a border of normal peritoneum was extracted 
[48]. We did not use barrier methods to prevent adhesions. 
Excised lesions were submitted for histological examination 
to confirm the diagnosis and analyse the status of inflamma-
tion and fibrosis. After surgery, long-term hormonal therapy 
was offered at the hospital to all women not trying to become 
pregnant.
The primary outcome was the confirmation of diagno-
sis, a change in pain symptoms, quality of life assessment 
and pregnancy in cases of patients who wanted children at 
the follow-up visit. A therapeutic response defined a > 50% 
reduction in symptoms. Patients who did not visit our outpa-
tient clinic were contacted by telephone at least three times.
Data evaluation and statistical analysis
Statistical analysis was performed using IBM SPSS Statis-
tics software, version 26 (IBM Corporation, Armonk, NY, 
USA). If data are missing, the total number of cases with 
available information is referred to. Categorical variables 
are reported as frequencies and percentages. Continuous 
variables are reported as the mean and standard deviation. 
Spearman’s correlation coefficient was used to compare non-
normally distributed variables. A within-group comparison 
was undertaken with the Wilcoxon rank-sum test for non-
parametric data. We performed a stepwise backward logistic 
regression to assess potential clinical characteristics inde-
pendently associated with pain scores. A value of p < 0.05 
was considered statistically significant.
Results
A total of 94 patients, who showed symptoms resistant to 
medical treatment and had received peritonectomy within 
a time period of 5 years at our endometriosis center, were 
included in this study. The follow-up data of 82 patients 
(87.23%) were available.
The average age of the patients was 29.40 years (± 6.751) 
at the time of surgery, 84.9% of women were nulliparous, 
15.1% were uni- or multiparous. 42.6% completed a preoper-
ative questionnaire, while the other patients were questioned 
in detail during a personal interview.
The vast majority (91.2%) of women had taken pain 
medication (non-steroidal anti-inflammatories or spasmolyt-
ics) before surgery without sufficient pain relief, and 68.1% 
women had taken at least one form of hormonal treatment 
(combined oral contraceptives, progesterone only pills or 
a contraceptive vaginal ring) (Table 2). Hormonal treat-
ment was interrupted at least 2 months prior to surgery in 
all cases.
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The majority of women had vegetative symptoms 
(59.4%), such as nausea, vomiting, headache, migraine, 
diarrhea and obstipation. About one-third (34.2%) indi-
cated nicotine abuse while nearly one-fifth (17%) suffered 
from depression (Table 2).
Primary surgical treatment was performed in one-half 
of cases. 43.6% of patients had previous abdominal surgi-
cal interventions for endometriosis. Accordingly, in about 
one-half of the patients’ endometriosis was diagnosed 
preoperatively.
Primary indications
Ultrasound examinations preoperatively revealed aden-
omyosis in three-quarters of the patients and any other 
pathological findings, such as the suspicion of extra ovar-
ian cysts or a malformation of the uterus, were found 
in 6.1%. In 18.3% a normal pelvic situs was diagnosed 
(Table 2).
86% of patients disclosed that they suffered from dys-
menorrhea, 67.4% had cyclic pain, 55.9% reported com-
plex chronic pain, 62.4% dyspareunia, 21.5% dysuria and 
35.5% dyschezia. For pain levels please see Table 3.
65.6% of women said they wanted to have a child pre-
operatively and impaired fertility was seen in about one-
half of these patients (Table 2), out of these three had fur-
ther problems complicating/aggravating fertility, namely 
Asherman, PCO and adrenogenital syndrome.
Intraoperative findings
Endometriosis was clinically confirmed in all cases on the 
basis of a conspicuous peritoneum. At the time of surgery, 
almost all women showed stage I or II endometriosis (44.7 
and 48.9%, respectively) as classified by the rASRM score. 
6.4% indicated stage III, in 17% of patients, in addition to 
pelvic peritoneal lesions, extragenital endometrial lesions 
were found outside of the pelvis, mainly on the diaphragm 
(Table 4). Of the 73 patients who underwent chromoper-
tubation, a bilateral fallopian patency was seen in 76.7% 
of cases, unilateral patency in 32.9% and no patency was 
found in 4.1%. There were no complications reported for 
the duration of the whole study. Residua of endometriosis 
had to be left for various reasons in seven women: missing 
Table 2  Characteristics of the patients included
*n = number of women included in this subanalysis, variation due to 
missing data
Age (years) ± SD 29.40 ± 6.751
Nulliparous *86 73 (84.9%)
Multiparous *86 13 (15.1%)
Pain killer preop. *57 52 (91.2%)
Hormonal treatment preop. *91 62 (68.1%)
Vegetative symptoms *64 38 (59.4%)
Nicotine *38 13 (34.2%)
Depression *88 15 (17%)
Adenomyosis sonographically *82 62 (75,6%)
Normal pelvic situs *82 15 (18.3%)
Other pathological finding *82 5 (6.1%)
First surgery 47 (50%)
Surgery for other reasons (such as appendectomy, 
ovarian cysts and emergency diagnostic laparos-
copy)
6 (6.4%)
Previous surgery for EM 41 (43.6%)
EM diagnosed preop. *93 49 (52.7%)
Child wish *93 61 (65.6%)
Impaired fertility *61 29 (47.5%)
Table 3  Presurgical symptoms
*n = number of women included in this subanalysis, variation due to 
missing data
Dysmenorrhea preop. *93 80 (86%)
Cyclic pain preop. *92 62 (67.4%)
CCP preop. *93 52 (55.9%)
Dyspareunia preop. *93 58 (62.4%)
Dysuria preop. *93 20 (21.5%)
Dyschezia preop. *93 33 (35.5%)
Strength of dysmenorrhea preop. average and max. 
(median)
7 and 9
Strength of cyclic pain preop. average and max. 
(median)
5 and 7
Strength of chronic pain preop. average and max. 
(median)
5 and 8
Strength of dyspareunia preop. average and max. 
(median)
4 and 7
Strength of dysuria preop. average and max. (median) 2 and 6
Strength of dyschezia preop. average and max. (median) 4 and 7
Table 4  Intraoperative findings
*n = number of women included in this subanalysis, variation due to 
missing data
Tubal patency 73 (87.7%)
No patency *73 3 (4.1%)
Patency both sides *73 56 (76.7)
Patency one side *73 24 (32.9)
rARSM I 42 (44.7)
rARSM II 46 (48.9%)
rARSM III 6 (6.4%)
EM genitalis externa 16 (17%)
Histological diagnosis: EM *90 25 (27.8%)
Histological diagnosis: EM and inflammation *90 54 (60%)
Histological diagnosis: inflammation *90 11 (12.2%)
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informed consent in case of unexpected incidental endome-
triosis of the diaphragm (two times) and superficial lesions 
on the large intestine (three cases), which were coagulated, 
or unsuspected deep infiltrating endometriosis on the sigma 
(two times).
88% had histologically confirmed endometriosis com-
bined with chronic inflammation, and fibrosis, and the 
remaining patients had signs of peritoneal inflammation/
fibrosis only (Fig. 1).
Post‑operative outcome
The mean time after which the follow-up question-
naire was completed was 14.86 months (± 12.792, range 
2–59 months).
Postoperative data showed a remarkable improvement in 
the quality of life of the majority of patients. More than 
three-quarters of women reported pain relief (Fig. 2). Of 
these patients, 23.8% reported symptom-free status and in 
52.5% of the women endometriosis-associated symptoms 
improved greatly. Significant results were reported postop-
eratively in fertility rates. Within the specified timeframe 
between performed surgeries to follow-up, 62.07% (18/29) 
of women with infertility problems became pregnant post 
surgically, seven women had already delivered, six women 
had an ongoing pregnancy, four patients had an abortion, one 
patient had a biochemical pregnancy (Fig. 3). Only three out 
of these 18 women needed assisted reproductive technology 
(ART).
Despite our insistent recommendation only 29.87% 
(23/77) of patients took postoperative hormonal treat-
ment (HT), 11 women rejected the hormonal therapy, 
seven women did not tolerate therapy, in one patient the 
gynecologist refused to prescribe HT. In six women mul-
timodal pain therapy was proposed. Twenty-nine patients 
wanted to get pregnant and consequently opted against 
HT (Table 5).
Symptoms decreased significantly after surgery in the 
majority of patients (Z − 4.330, p < 0.000). In comparison 
to the group of women without HT post surgically, there 
was a significant decrease of pain in the HT-group (Figs. 4, 
5). After analyzing the effect of pre-operation on the out-
come, there were no significant differences between the 
two groups. In seven women a re-operation was performed 
(see Table 6). The evidence of recurrence was confirmed in 
only two patients, one of which wished to conceive. This 
patient underwent fertility treatment for the last 2 years and 
due to the progression of symptoms and the status of the 
fallopian tubes we decided to do laparoscopy again. She 
became pregnant (biochemical pregnancy) after our second 
intervention. The other patient rejected post-surgical hor-
monal treatment. The main problem facing the other women 
Fig. 1  some acute and chronic inflammatory cells, psammomatous calcification
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Fig. 2  Significant difference between symptoms before and after surgery presented by box-plots. Pain score divided into 4 categories: 4: severe 
(VAS 8–10), 3: modeste (VAS 5–7), 2: mild (3–4), 1: no pain
Fig. 3  Fertility rate after surgery
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was severe adenomyosis. At re-operation, we could see the 
intact/regrown peritoneum without any signs of inflamma-
tion (Fig. 5). We did not detect an excessive presence of 
adhesions.
Correlation analysis and logistic regression revealed no 
effect on the influential parameters of the pain scores and 
postoperative symptoms.
Discussion
In summary, endometriosis was clinically confirmed in all 
cases and laparoscopic excision in our cohort was beneficial 
in reducing pain, thus improving the patient’s quality of life 
and enhancing the chance of pregnancy of women in the 
early stages of endometriosis for more than 1 year following 
the check-up. However, to achieve these objectives, a well-
considered selection for surgery in endometriosis patients is 
crucial and adequate timing guarantees the highest benefit 
[50]. Endometriosis has to be understood as a chronic dis-
ease which needs individual concepts. Especially the first 
surgery has to be planned and performed very carefully [51]. 
Early and recurrent surgeries due to inadequate evidence 
have to be avoided, as it is well known that endometriosis 
patients generally need multiple surgeries and have a poor 
physical and mental health status, and there is a higher 
chance that disease recurrence happens [52].
Table 5  Follow-up
*n = number of women included in this subanalysis, variation due to 
missing data
Time of follow-up (range) 14.86 ± 12.792 (2–59)
Re-operation *83 7 (8.4%)
No pain after surgery *80 19 (23.8%)
Symptoms improved after surgery *80 42 (52.5%)
Symptoms unchanged/worse after surgery *80 19 (23.8%)
Child wish post surgically *81 29 (35.80)
Deliveries *29 7
Ongoing pregnancies *29 6
Abortion *29 5
ART *18 3 (16.7%)
Hormonal therapy (HT) after surgery *77 23 (29.87%)
HT rejected *77 11 (14.29%)
HT not tolerated *77 7 (9.09%)
Multimodal pain therapy *77 6 (7.8%)
Fig. 4  Symptoms post surgi-
cally according to hormonal 
therapy
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The success rates for reducing the characteristic symp-
toms of endometriosis have been stated in the literature and 
are similar to the results we found in our study. Almost 25% 
were non-responders in a recent study by Ghai et al. on 102 
women with superficial endometriosis, independent on the 
surgical method (excision or ablation) [53]. Interestingly, 
women were more likely to be non-responders if treated for 
early-stage endometriosis compared with those with severe 
endometriosis. One reason for this might be that surgeries 
are often done under hormonal treatment like combined oral 
contraception, so the extent of peritoneal endometriosis is 
underestimated and implants are left. One study by Strowit-
zki et al. clearly showed a downstaging of peritoneal endo-
metriosis under hormonal treatment with dienogest [54]. 
However, data on presurgical suspended hormonal therapy 
are usually missing.
The pelvic peritoneum appears to play a key role in the 
development and maintenance of endometriosis. The attempt 
of hormonal therapy before surgery helps to identify patients 
with exclusively acyclic pain resistant to hormonal treatment 
as an indication for the occurrence of peritoneal lesions with 
neurogenic inflammation. Such patients might have a benefit 
from the excision of these lesions. Accordingly, it was shown 
that the removal of peritoneal lesions remarkably decreased 
not only the pain level, but the low pain threshold went back 
to the normal level of healthy controls [55–57]. Another 
benefit of excision is the histologic confirmation of the dis-
ease. Nearly 100% of our patients had an altered peritoneum 
with a histologically proven disease and/or inflammation. 
Histologic diagnosis is, however, dependent on pathologist’s 
experience [58].
The patients’ hormonal therapy had been stopped before 
surgery (minimum 2 months prior to surgery) due to the 
chance of failure. So, the altered peritoneum was more vis-
ible and glassy lesions and inflammation could be removed. 
Interestingly not only the endometriotic lesions could be 
confirmed, but also the presence of inflammation in nearly 
75% of cases. This extended inflammatory reaction might 
be underestimated as an essential part of pain generation. 
However, certain patients suffered from persistent pelvic 
pain after the excision of endometriosis. This might also be 
associated with adenomyosis, a main cause of dysmenor-
rhea. During sonography examinations, it was discovered 
that three-quarters of women in our cohort had adenomyosis. 
It is well known that in up to 90% of the cases, endometriosis 
and adenomyosis appear at the same time [59].
In more than 20–25% of patients, pain still remains a 
part of their daily life despite the well processed surgical 
or hormonal treatment [60]. Similarly, in our cohort 23.7% 
of patients experienced no benefit after surgery (Table 5). 
However, 11 of them (57.9%) rejected adjuvant hormonal 
treatment.
Our renewed surgery rate is low (8.54%) compared to 
the probability of a further surgical procedure of about 
15–20% according to literature and this may be attributed 
to the correct suspicion of peritoneal endometriosis and the 
adequate excision of all areas of abnormal peritoneum (peri-
toneal lesions and inflamed altered tissue without hormonal 
downregulation) with a sufficient safety margin in all cases 
Fig. 5  Description of cohort of patients. HT hormonal therapy
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[61–63]. An earlier report demonstrated that one-quarter of 
the patients with proven peritoneal endometriosis already 
had microscopic endometriotic implants in their peritoneum 
that were otherwise deemed normal [64]. And others showed 
recurrent endometriotic lesions especially in the margin of 
earlier resection areas [65]. We recommend hormonal treat-
ment following surgery to all our patients with the aim to 
prevent recurrence [66, 67].
In patients who received further surgery after extensive 
peritonectomy, all but two had no evidence of endometrio-
sis, neither macroscopically nor histologically at the time of 
re-operation. This does not signify that endometriosis has 
not been the cause of pelvic pain but proves the concept 
of chronic long-term pain which may be a consequence of 
the up-regulation of pain sensitization and not recurrent dis-
ease. Such pain may not go away even after hormonal and/
or surgical therapy [68]. These chronic pain patients suf-
fer from spinal hyperalgesia, myofascial pain syndrome or 
pelvic floor muscle imbalance. Chronic pain is an interplay 
of pathophysiological, psychological and social factors. 
The complexity of pain sensation and perception have to be 
addressed. We recommend multifaceted care models includ-
ing pain management programs, nutrition advice, counseling 
and education, osteopathy, and psychological therapies 
alongside gynecologic treatments to affected women [69].
Based on two older contradictory studies and a 
Cochrane review comparing laparoscopic surgical treat-
ment with diagnostic laparoscopy only in minimal and 
mild endometriosis, the laparoscopic surgery had better 
results for pregnancy after 20 weeks, regardless of the 
surgical method [29–31]. The odds ratio of 1.65 and the 
number needed to treat of 12 are though viewed critically 
[61]. In a comparison of the basic chance of pregnancy 
of about 20% our pregnancy rate is pleasantly more than 
three times higher. In our view, the surgical removal of 
peritoneal implants with a safety margin address the noci-
ceptive as well as the neurogenic inflammatory pathway 
of pain caused by endometriosis. Maybe the excision of 






Indication Surgery Intraop. findings Postop. therapy Outcome
Case 1 No 2 years Persistent pain, 
increased ten-







No EM at 
2nd surgery. 
rARSM I and 




HT after 1st 
surgery. Fertil-
ity treatment 
(2 × IVF) after 
2nd surgery
Biochemical preg-
nancy after 3rd 
surgery
Case 2 1 year before our 
surgery, not 
clear if HT
2 years Cyclic pain, dys-
menorrhea
Peritonectomy rARSM II Rejects HT, 
takes cortisone 
therapy
1 year after surgery 
again incipient 
neurogenic pain









HT 1 year after surgery 
again incipi-




Case 4 7 years before 
our first op, not 
clear if HT
2 years Emergency for 
acute pain










1/2 year Upon request Hysterectomy Severe AM, no 
EM
No therapy Symptoms 
improved after 
hysterectomy
Case 6 no 4 1/2 years Persistent pain, 
spinal hyperal-
gesia
Diagnostic, IUD Severe AM, no 
EM
Rejects therapy Asks for hysterec-
tomy
Case 7 1 year before our 
surgery, not 
clear if HT
2 years Upon request Diagnostic No EM HT
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the inflamed tissue affects fertility. We recommend timely 
and comprehensive surgical management and determined 
fertility treatment in patients wishing to conceive consid-
ering the higher chance of conception within 2 years of 
surgery and the negative impact of repeated surgery on 
fertility outcomes [50] (see Fig. 6).
Strengths
One methodological strength of this study is the standard-
ized documentation of clinical data and pain history on a 
dedicated questionnaire in the majority of cases. Surgery 
was done with the expectation of peritoneal endometriotic 
lesions and good and uniform preparation of the patients. All 
interventions were done by a single high-volume minimally 
invasive gynecologic surgeon with a focus on endometriosis. 
Consistent techniques were performed throughout the dura-
tion of the study. All patients had to discontinue their choice 
of standard medical suppression treatment for endometriosis 
at least 2 months before surgery. All women were evaluated 
and treated by physicians with long-standing and extensive 
expertise in the management of endometriosis. This is indi-
rectly confirmed by the observation that endometriosis was 
confirmed in all cases. In addition, the follow-up interviews 
were performed mainly face-to-face, reducing the risk of 
recall bias. Our follow-up rate was high compared to other 
studies (61.61% in Yeung et al., 60.3% in Riley et al. [70, 
71]).
Limits
Regarding the limitations of this study, many women 
(43.6%) had previously been operated on due to symptoms 
of endometriosis, prior to having surgical excision. It is pos-
sible that this may bias the outcome, with women being pre-
selected because they had had a previously failed therapy. 
This highlights two points: the first is that the perfect treat-
ment has yet to be found. All current available treatments 
have a significant “failure rate” as noted by the recurrence of 
pain and the desire for further treatment. The second is that 
endometriosis is a very individual chronic disease requiring 
different treatments depending on the patient’s particular 
phase of life. Interestingly our surgeries on women, who 
had been operated previously, were as successful as first time 
interventions. One possible explanation could be that the 
first operations had been performed under hormonal therapy 
(Fig. 7).
The design was one cohort and the time of follow-up 
was inconsistent. With the given sample size of the study, it 
cannot be excluded that some of the observed effects could 
be clouded by subsequent medical or surgical treatment not 
reported by patients or recorded in our medical files.
We do not have the post-surgical VAS scores of symp-
toms. An important change for the patient may be one that 
represents a meaningful reduction in symptoms or improve-
ment in HRQoL from her point of view. Vincent et al. sug-
gest that the definition of a responder in endometriosis cor-
responds to a > 30 or > 50% reduction in symptoms [72]. We 
Fig. 6  Surgical site before surgery (a), after surgery (b) and at re-operation (c–e)
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classified trial participants as a responder who called them-
selves a responder by having had a subjectively satisfying 
response to therapy (> 50% reduction in symptoms).
It is possible that the results of this study may be 
affected by the 12.77% of women who were not reached 
for follow-up, since subjects lost to follow-up notoriously 
have a worse prognosis [43]. We compared responders 
with non-responders. Based on this analysis it is unlikely 
that the results would be significantly altered by women 
who were not included in the follow-up cohort.
Summary
We understand endometriosis as a complex and multifacto-
rial disease. Patients with endometriosis need individual 
management of the disease regarding the personal situa-
tion (symptoms and family planning). Early and recurrent 
surgeries for diagnosis only without any therapeutical con-
cept have to be avoided [50, 51]. Long-term treatment with 
hormones and multimodal concepts are needed.
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